1894
Tomokichi Fujisawa founded Fujisawa Shoten in Osaka
1897
Launched "Fujisawa Camphor" as a home-use insect repellent
1943
Changed the company name to Fujisawa Pharmaceutical Co., Ltd.
1964
Central Laboratory completed
1971
Launched "Cefamezin," an antibiotic for injections
Proceeds to market it worldwide.
1977
Established Fujisawa Pharmaceutical Corp. in the U.S.
The company's first business base in the U.S.
1979
Opened a London Office, the company's first business base in Europe
1983
Tsukuba Laboratory completed
1991
Established Fujisawa Europe GmbH in Germany
1993
Launched immunosuppressant "Prograf"
Currently sold in about 100 countries
1998
Restructured the business in the U.S., founds Fujisawa Healthcare, Inc.
1999
Launched "Protopic," an agent to treat atopic dermatitis
Currently sold in about 60 countries
2004
OTC businesses of both companies were integrated in October 1, 2004 to form Zepharma Inc.
2005
Apr. 1, 2005 Astellas Pharma Inc. was established